Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)

Today's Latest Price: $150.71 USD

0.29 (-0.19%)

Updated Dec 4 4:00pm

Add JAZZ to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 389 in Biotech

See all "A" rated Strong Buy stocks

Jazz Pharmaceuticals plc (JAZZ) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Jazz Pharmaceuticals plc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
18 $233 $145 $181.67 $151 20.31%

JAZZ Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.19 15 1 1 1 1 18

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • JAZZ has a greater average analyst price target than 96.3% of Pharmaceutical Products stocks.
  • JAZZ has a higher number of analysts covering the stock than 95.42% of Pharmaceutical Products stocks.
  • The percentage of analysts bullish on the stock of JAZZ is higher than 94.09% of stocks in the large market cap category.
  • Jazz Pharmaceuticals plc's percent of analysts bearish on the stock is lower than 16.59% of Pharmaceutical Products stocks.
  • JAZZ has a greater upside potential (average analyst target price relative to current price) than 83.37% of stocks in the large market cap category.
  • JAZZ has a less variance in analysts' estimates than 27.87% of all US stocks.
  • Jazz Pharmaceuticals plc's change in bullishness amongst analysts is less than almost 100% of all US stocks.

In the Pharmaceutical Products industry, MDGL, GWPH and ABT are the three stocks most similar to Jazz Pharmaceuticals plc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding JAZZ using the data that counts. Try POWR Ratings for free.



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5889 seconds.